Literature DB >> 19833577

Confirmation of hypoglycemia in the "dead-in-bed" syndrome, as captured by a retrospective continuous glucose monitoring system.

Robert J Tanenberg1, Christopher A Newton, Almond J Drake.   

Abstract

OBJECTIVE: To report a case that substantiates the presence of hypoglycemia at the time of death of a young man with type 1 diabetes, who was found unresponsive in his undisturbed bed in the morning.
METHODS: We describe a 23-year-old man with a history of type 1 diabetes treated with an insulin pump, who had recurrent severe hypoglycemia. In an effort to understand these episodes better and attempt to eliminate them, a retrospective (non-real-time) continuous subcutaneous glucose monitoring system (CGMS) was attached to the patient. He was found dead in his undisturbed bed 20 hours later. The insulin pump and CGMS were both downloaded for postmortem study.
RESULTS: Postmortem download of the data in the CGMS demonstrated glucose levels below 30 mg/dL around the time of his death, with only a minimal counter-regulatory response. This finding corresponded to a postmortem vitreous humor glucose of 25 mg/dL. An autopsy showed no major anatomic abnormalities that could have contributed to his death.
CONCLUSION: To our knowledge, this is the first documentation of hypoglycemia at the time of death in a patient with the "dead-in-bed" syndrome. This report should raise the awareness of physicians to the potentially lethal effects of hypoglycemia and provide justification for efforts directed at avoiding nocturnal hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19833577     DOI: 10.4158/EP09260.CR

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  66 in total

1.  Case files of the Harvard Medical Toxicology Fellowship at Children's Hospital Boston: an insulin overdose.

Authors:  Aaron Benjamin Skolnik; Michele Burns Ewald
Journal:  J Med Toxicol       Date:  2010-12

Review 2.  Glycemic control and weight reduction without causing hypoglycemia: the case for continued safe aggressive care of patients with type 2 diabetes mellitus and avoidance of therapeutic inertia.

Authors:  Stanley S Schwartz; Benjamin A Kohl
Journal:  Mayo Clin Proc       Date:  2010-11-24       Impact factor: 7.616

Review 3.  State of the art of clinical islet transplantation and novel protocols of immunosuppression.

Authors:  A M James Shapiro
Journal:  Curr Diab Rep       Date:  2011-10       Impact factor: 4.810

Review 4.  Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systems.

Authors:  Tandy Aye; Jen Block; Bruce Buckingham
Journal:  Endocrinol Metab Clin North Am       Date:  2010-09       Impact factor: 4.741

Review 5.  Hypoglycemia and Cardiovascular Disease: Lessons from Outcome Studies.

Authors:  Frank Pistrosch; Markolf Hanefeld
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

6.  Death during intensive glycemic therapy of diabetes: mechanisms and implications.

Authors:  Philip E Cryer
Journal:  Am J Med       Date:  2011-11       Impact factor: 4.965

7.  Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities.

Authors:  Laura Boucai; William N Southern; Joel Zonszein
Journal:  Am J Med       Date:  2011-11       Impact factor: 4.965

Review 8.  Encapsulated Islet Transplantation: Where Do We Stand?

Authors:  Vijayaganapathy Vaithilingam; Sumeet Bal; Bernard E Tuch
Journal:  Rev Diabet Stud       Date:  2017-06-12

9.  Innovations in technology for the treatment of diabetes: clinical development of the artificial pancreas (an autonomous system).

Authors:  David C Klonoff; Charles L Zimliki; Lcdr Alan Stevens; Patricia Beaston; Arleen Pinkos; Sally Y Choe; Guillermo Arreaza-Rubín; William Heetderks
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

10.  Factors associated with nocturnal hypoglycemia in at-risk adolescents and young adults with type 1 diabetes.

Authors:  Darrell M Wilson; Peter M Calhoun; David M Maahs; H Peter Chase; Laurel Messer; Bruce A Buckingham; Tandy Aye; Paula K Clinton; Irene Hramiak; Craig Kollman; Roy W Beck
Journal:  Diabetes Technol Ther       Date:  2015-03-11       Impact factor: 6.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.